We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FANG icon
601
Diamondback Energy
FANG
$56B
$1.71M 0.01%
9,898
+817
+9% +$157K
CNI icon
602
Canadian National Railway
CNI
$78.5B
$1.71M 0.01%
14,565
-1,396
-9% -$163K
VRSK icon
603
Verisk Analytics
VRSK
$27.9B
$1.7M 0.01%
6,341
-160
-2% -$43.3K
G icon
604
Genpact
G
$6.22B
$1.69M 0.01%
43,156
+926
+2% +$33.5K
CMC icon
605
Commercial Metals
CMC
$7.53B
$1.69M 0.01%
30,689
+1,122
+4% +$60.7K
PANW icon
606
Palo Alto Networks
PANW
$256B
$1.69M 0.01%
9,860
-2,198
-18% -$370K
NOVT icon
607
Novanta
NOVT
$4.91B
$1.67M 0.01%
9,344
+46
+0.5% +$8K
BN icon
608
Brookfield
BN
$102B
$1.66M 0.01%
46,902
-4,380
-9% -$138K
BRO icon
609
Brown & Brown
BRO
$25.1B
$1.66M 0.01%
16,031
-3,995
-20% -$397K
CWST icon
610
Casella Waste Systems
CWST
$5.76B
$1.66M 0.01%
16,687
-1,213
-7% -$126K
NU icon
611
Nu Holdings
NU
$67.8B
$1.66M 0.01%
121,298
-8,814
-7% -$119K
SYF icon
612
Synchrony
SYF
$24.4B
$1.65M 0.01%
32,982
-5,842
-15% -$283K
CPNG icon
613
Coupang
CPNG
$27.2B
$1.62M 0.01%
66,158
-1,493
-2% -$33.2K
TMHC
614
DELISTED
Taylor Morrison
TMHC
$1.6M 0.01%
22,784
+565
+3% +$36.2K
EVRG icon
615
Evergy
EVRG
$19.4B
$1.59M 0.01%
25,698
-4,821
-16% -$281K
CF icon
616
CF Industries
CF
$19.6B
$1.59M 0.01%
18,553
+30
+0.2% +$2.32K
NEM icon
617
Newmont
NEM
$96.2B
$1.58M 0.01%
29,642
+2,199
+8% +$109K
IYW icon
618
iShares US Technology ETF
IYW
$22.6B
$1.58M 0.01%
10,441
– –
MTB icon
619
M&T Bank
MTB
$36.3B
$1.58M 0.01%
8,873
+238
+3% +$39.5K
EXPO icon
620
Exponent
EXPO
$3.19B
$1.57M 0.01%
13,656
-278
-2% -$29.1K
XLP icon
621
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$1.57M 0.01%
18,863
-6,718
-26% -$539K
ATMU icon
622
Atmus Filtration Technologies
ATMU
$4.12B
$1.55M 0.01%
41,275
+303
+0.7% +$9.89K
SW
623
Smurfit Westrock
SW
$25.3B
$1.54M 0.01%
+31,104
New +$1.41M
ICUI icon
624
ICU Medical
ICUI
$4.16B
$1.53M 0.01%
8,401
-393
-4% -$58.2K
HAL icon
625
Halliburton
HAL
$26.1B
$1.52M 0.01%
52,376
-491,845
-90% -$15.5M
23 24
25
26 27

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.